This term refers to cannabis products legally available for purchase and consumption by individuals who are at least 21 years old. Unlike medical cannabis, adult-use cannabis is accessed primarily for recreational, rather than therapeutic, purposes.
The process of returning cannabis products to a licensed cultivator or manufacturer, typically due to expiring product, failing quality control, or product recalls.
Trace amounts of solvents left behind after cannabis extraction processes. Regulatory limits exist to ensure consumer safety.
Cannabinoids naturally produced by the cannabis plant. THC, CBD, CBG, CBN, and CBC are some of the most well-known examples.
Cannabinoids in the cannabis plant that do not produce an intoxicating effect, such as CBD, CBG, CBN, and CBC. These cannabinoids are gaining research interest for potential therapeutic benefits.
The application of science and engineering at the atomic and molecular level. This emerging technology has potential applications in the cannabis industry, such as for developing targeted cannabinoid delivery systems or enhancing the bioavailability of cannabinoids.
A small cannabis business operating within specific regulatory limitations, such as production capacity, retail sales volume, or number of employees. Microbusiness licenses can be a good entry point for smaller entrepreneurs in the cannabis industry.
Regulations that allow individuals to cultivate a limited number of cannabis plants for personal use at home.
Cannabidiol that is extracted from industrial hemp plants, which contain 0.3% or less THC.
